High plasma C-reactive protein (hs-CRP) levels and arterial stiffness are risk factors for cardiovascular diseases. Pulse wave velocity (PWV) and augmentation index (AIx) have been found to be elevated in patients with vascular inflammation, diabetes mellitus, hypertension, hypercholesterolemia and in smokers. We investigated the relation of high-sensitivity CRP (hs-CRP) with aortic stiffness in 362 men. The levels of hs-CRP were measured using a nephelometric method. Aortic PWV and AIx were assessed from carotid-femoral segment and radial artery waveforms with the use of the SphygmoCor device. In the crude model, aortic PWV increased significantly with increasing serum hs-CRP levels; PWV increased by 2.48 m/s (95% CI 1.58; 3.38) in the fifth compared to the first quintile of hs-CRP. In the adjusted model, the PWV increased by 0.84 m/s (95% CI 0.13; 1.55) in the fifth quintile compared to the first quintile (P-value was 0.02). In the crude model, AIx increased significantly with increasing serum hs-CRP levels; AIx increased by 7.17% (95% CI 3.72; 10.62) in the fifth versus the first quintile. Adjusted for confounders, AIx remained 4.57% (95% CI 1.32; 7.82) higher in the fifth compared to the first quintile (P-value for trend was o0.01). More adjustment for subclinical atherosclerosis attenuated the b-coefficient for PWV (difference 0.71 m/s (95% CI 0.01; 1.41), but not for AIx (4.60% (95% CI 1.34; 7.85)). In summary, low-grade inflammation seems to be independently related to increase of aortic artery stiffness over and above traditional risk factors and atherosclerosis.
Introduction
Inflammation and arterial stiffness are being increasingly recognized as important determinants of cardiovascular disease (CVD). [1] [2] [3] Epidemiological studies have shown that elevated levels of inflammation markers, in particular high-sensitivity C-reactive protein (hs-CRP), are associated with a higher risk of CVD independent of traditional cardiovascular risk factors in healthy subjects. 4, 5 Arterial stiffening occurs as a consequence of aging and is increased in the presence of risk factors for atherosclerosis such as hypertension, diabetes mellitus, hypercholesterolemia and smoking. [6] [7] [8] There is evidence suggesting that aortic pulse wave velocity (PWV) and wave reflections as assessed by augmentation index (AIx) are associated with an increased risk of cardiovascular disease in young and middle-aged men. 9 PWV and AIx have been found to be elevated in patients with active arteritis. 10 Although some studies in healthy subjects also suggest a relationship between CRP and arterial stiffness measured by PWV or arterial wave reflections measured by AIx 11, 12 , other studies do not. 13 This study was, therefore, conducted to determine the association of serum hs-CRP levels with carotid-femoral PWV and radial AIx in a population-based sample of men living independently.
Subjects and methods

Subjects
HAMLET is a population-based cohort of men (n ¼ 400) aged from 40 to 80 years and healthy enough to visit our study centre at the time of enrolment. Subjects were recruited from two sources. First, the male partners of 770 randomly selected female participants in a previous study conducted by the Julius Center were invited to participate. A total of 240 (31%) participated.
Then, 1230 men were randomly selected from the municipal register of Utrecht, a town in central Netherlands. Of this group, 390 (32%) men were willing to participate. From the total of 630 potential volunteers, 16 subjects were excluded because they were not physically or mentally able to visit the study centre. Of the remaining 614 men, 400 men were randomly selected to participate in this study, with equal numbers in each age-decade across a range of 40-80 years. Data collection took place between March 2001 and April 2002, and participants visited the research centre twice. Fasting venous blood samples were taken between 0800 and 1000, and platelet-free serum was obtained by centrifugation. The serum was immediately stored at À201C and within a week moved to À801C. The study was approved by the Institutional Review Board of the University Medical Center Utrecht and written informed consent was obtained from all participants.
hs-CRP measurement hs-CRP was measured using a Behring Nephelometer P (Dade Behring, Liederbach, Germany). The lower limit of detection was 0.175 mg/l and the interassay variation was 2.4%.
Assessment of aortic PWV and AIx
The PWV was determined noninvasively using a SphygmoCor device (PWV Medical, Sydney, Australia), which allowed an online pulse wave recording and automatic calculation of PWV using transducers (Millar SPT 301 pressure transducer; Milar Instruments, Sydney, Australia). Details of the procedure for aortic PWV measurement have been published previously. 14 The aortic AIx was derived by applantation tonometry of the radial artery and was calculated as the difference between the first and second systolic peaks of the ascending aortic waveform expressed as a percentage of the central pulse pressure (the difference between central systolic and diastolic pressure divided by pulse pressure). The details of this method have been described elsewhere. 15 Other measurements A medical doctor obtained information on prevalent diseases and the details of medication used by taking a specified medical history. Height, weight, and waist and hip circumference were measured with the participant in standing position wearing indoor clothes and no shoes. Waist-to-hip ratio was calculated by dividing waist-to-hip circumference. Using a semi-automated device (Dinamap 8100; Critikon Inc., Tampa, Finland), brachial artery blood pressure was measured twice in the morning after a 10 min rest, with the subject lying down. The average of the two measurements of systolic and diastolic blood pressure (SBP and DBP) was used for analysis. The mean arterial blood pressure (MAP) was calculated as DBP þ (1/3 (SBP-DBP)). Pulse pressure values were obtained from the difference between SBP and DBP. Hypertension was defined as SBP X140 mm Hg and/or DBP X90 mm Hg or use of antihypertensive medication. Smoking was estimated from self-report and smoker's status was categorized in current, former and never. Fasting total cholesterol and triglycerides were measured using an automatic enzymatic procedure (Synchron LX Systems, Beckman Coulter, Fullerton, CA, USA). Diseases were considered present when participants reported a physician's diagnosis and were classified according to the International Classification of Diseases, 10th version (ICD-10). Diabetes mellitus was considered present when participants reported treatment with insulin or oral hypoglycaemic agents and/or had a fasting plasma venous glucose (capillary) level 46.9 mmol/l. CVD was considered present if there was pre-existing coronary heart disease, peripheral artery disease or stroke. Carotid intimamedia thickness (CIMT) was used to assess the extent of subclinical atherosclerosis. Ultrasonography of both the left and right carotid arteries was performed using a 7.5 MHz linear array transducer (Acuson Aspen, Mountain View, CA, USA). Details of the procedure for CIMT measurement have been published previously. 16 
Data analysis
Of the 400 subjects who participated in the HAM-LET study, aortic PWV and AIx were measured in 378 subjects. Missing information on both measures was entirely due to logistic reasons. Two extreme values in PWV (2.75 and 30.51 m/s) have been excluded, since they were considered biologically implausible. hs-CRP levels 410 mg/l can be taken as evidence of active inflammatory processes (for example, trauma, infection), therefore subjects with hs-CRP410 mg/l were excluded from the analysis (n ¼ 16). After exclusion for high hs-CRP levels and missing PWV and AIx data, the final study population comprised 362 men.
We examined the normality assumptions for the variables by the Kolmogorov-Smirnov test. We used one-way analysis of variance (ANOVA) or KruskalWallis test, according to the distributions of variables. Differences in proportions were tested using w 2 statistic. Linear regression analysis was used to assess the relationship between serum hs-CRP levels and PWV or AIx as the dependent variable. Quintiles of serum hs-CRP levels were used as dummy variables in the models because of its skewed distribution. Crude models were adjusted in three steps, first we added the risk factors that are always necessary for arterial stiffness to take into account the effect of age, mean arterial pressure, pulse pressure and heart rate. Additionally, we adjusted for the classical cardiovascular risk factors, namely waist-to-hip ratio, prevalent CVD, diabetes mellitus, hypertension, smoking status, total cholesterol, triglyceride, HDL and, in the case of Aix, also for height. To limit the effect of subclinical atherosclerosis on the probable association of hs-CRP and arterial stiffness, additional adjustments were made for CIMT. The AIx was finally adjusted for PWV. Furthermore, subgroup analysis was carried out for antihypertensive and antilipid medication use (yes/no). The data were analysed using the SPSS statistical package for Windows version 12.0 (SPSS Inc., Chicago, IL, USA). Table 1 shows baseline characteristics of the study population. Mean age of subjects was 60 years (range 40-80), and the median hs-CRP level was 1.3 mg/l (interquintile range 0.60-2.70). The cutoff points for the quintiles of hs-CRP were 0.6, 1.1, 1.9, 3.6 mg/l. Table 2 shows the distribution of potentially confounding variables across quintiles of hs-CRP. Subjects with the higher serum hs-CRP levels were older and had higher proportion of hypertension, diabetes mellitus, smoking and previous history of cardiovascular disease.
Results
In the crude model, aortic PWV increased significantly with increasing serum hs-CRP levels; PWV in the second, third, fourth and fifth compared to the first quintile of hs-CRP increased by 1.28 m/s (95% CI 0.45; 2.11), 1.47 m/s (95% CI 0.63; 2.30), 1.75 m/s (95% CI 0.91; 2.59) and 2.48 m/s (95% CI 1.58; 3.38). After adjustment for confounders, the relationship attenuated, but aortic PWV still increased in the highest quintile versus the first quintile of serum hs-CRP (increased by 0.84 m/s (95% CI 0.13; 1.55, P-value was 0.02 (Table 3) ). However, extra adjustment for CIMT attenuated the estimated effect, but still this association remained borderline significant for the highest versus to the first quintile of hs-CRP (PWV increased by 0.71 m/s (95% CI 0.01; 1.41)).
AIx similarly increased with increasing hs-CRP levels. In the crude model, AIx for the second, third, fourth and fifth versus the first quintile of hs-CRP increased by 4 (Table 4) .
Since the speed of aortic augmented waves from peripheral arteries depends on central arterial stiffness, we then further adjusted the AIx results for PWV. Although the relationship weakened, it remained statistically significant in the third, fourth and fifth quintiles versus the first quintile. AIx in the fifth quintile compared to the first quintile of hs-CRP increased by 4.15% (95% CI 0.91; 7.40) (P-value was 0.01). Use of blood pressure-lowering drugs or lipid-lowering agents did not modify the associations between hs-CRP and PWV or AIx (data not shown).
Discussion
In this study, we found a significant association of hs-CRP levels with aortic PWV and AIx in a population-based sample of middle-aged and elderly men living independently, which was unrelated to their subclinical atherosclerosis and other cardiovascular risk factors.
To appreciate the finding of this study, some aspects need to be discussed. In this study, hs-CRP is measured as a continuous variable, however, when inspecting our data in the quintiles, a threshold effect was visible (with the highest b-coefficient for the fifth quintile), in particular for PWV. This is reflected in the nonsignificant test for linear trend. When forcing a linear relationship through the data with a continuous (log hs-CRP) variable, the association with log hs-CRP becomes borderline significant (data not shown).
Our findings of a significant relationship between hs-CRP levels and aortic PWV as well as AIx are consistent with those obtained from previous studies. In a population-based sample of 214 asymptomatic middle-aged men and women, Kullo et al.
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noted that CRP was significantly and independently related to AIx, and borderline significantly related to PWV. Similarly, an independent relation between Table 3 Multiple linear regression b-coefficients and 95% confidence intervals, standardized b-coefficients and explained variance R 2 describing the association between CRP quintiles compared to lowest quintile as reference (independent variable) and PWV (dependent variable) Additionally adjusted for age, mean arterial pressure, pulse pressure, heart rate, waist-to-hip ratio, CVD, DM, hypertension, smoking, total cholesterol, triglyceride and HDL. Abbreviations: AIx, augmentation index; CIMT, carotid intima-media thickness; CRP, C-reactive protein; CVD, cardiovascular disease; DM, diabetes mellitus; HDL, high-density cholesterol; hs-CRP, high-sensitivity C-reactive protein; PWV, pulse wave velocity. CRP and AIx has been shown in 158 asymptomatic middle-aged individuals by Kampus and colleagues 11 . In addition, based on a study carried out in apparently healthy UK adults, Yasmin et al. 17 noted CRP only to be related to PWV. In the studies of Nagano et al. 18 Mattace-Raso et al. 19 and Saijo et al.
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CRP was significantly and independently associated with PWV. Occasionally, the association between CRP and PWV was not retained after adjustment for cardiovascular risk factors. 13 This study has some limitations. The interpretability of the results may be restricted by several factors inherent to the cross-sectional design and does not provide direct evidence of cause and effect. We cannot exclude that changes in the arterial physiology, as manifested in altered wave reflection, may precede elevation in CRP levels. It has been shown that altered flow patterns in arteries have been found to increase the expression of adhesion molecules. 21 In addition, we used single measurements of hs-CRP instead of a mean of multiple measurements. However, it has been reported that in most clinical settings, a single CRP assessment is likely to be adequate as long as levels of less than 10 mg/l are observed. 22 Although there are many published papers showing that CRP is a potent risk factor for clinical cardiovascular disease, there is scarcity of clinical data regarding the potential aetiological link between CRP and cardiovascular complications. The associations that we observed between measures of arterial stiffness and CRP add to the evidence that there is a relation between subclinical inflammation and functional alteration of large arterial bed and preclinical arterial remodeling (a true prequel to cardiovascular events).
The exact mechanisms responsible for arterial stiffening by inflammation remain to be elucidated. It has been shown that arterial stiffening is caused by both functional and structural alterations in the walls of the major conduit arteries resulting in an increase in PWV and alteration in the timing of reflected waves from the periphery. A number of circulating and endothelium-derived factors, including nitric oxide influence large artery stiffness. 23, 24 Inflammation is associated with endothelial dysfunction, which may lead to functional stiffening of the large arteries due to reduced nitric oxide bioavailability and increased activity of opposing mediators such as endothelin-1. 25, 26 Endothelial dysfunction may lead to a number of changes in the extracellular matrix including smooth muscle cell proliferation and increased synthesis of structural proteins including collagen as well. 27 Moreover, an increase in circulating inflammatory mediators directly promotes white cell infiltration into arteries, and a change in vascular smooth muscle phenotype. These cells release a number of elastin degradants, which can cause arterial stiffening. In inflammatory conditions, vascular smooth muscle cells also express osteoblast markers and can take up phosphate to produce bioapatite, which leads to reduced arterial elasticity. 28 The change in proteoglycan composition and hydration has been suggested as another cause of arterial wall stiffening in inflammatory situation. Finally, perivascular inflammation and cellular infiltration around the vasa vasorum may lead to vessel ischaemia which may also promote matrix remodeling and ultimately stiffening of the vessels. 29 Furthermore, vascular hs-CRP production may be stimulated by local expression of cytokines such as interleukin-6 and interleukin-1. In addition, hs-CRP has been reported to inhibit endothelial nitric oxide synthase, and to induce the expression of monocyte chemo-attraction protein-1 and adhesion molecules in human endothelial cells. This type of endothelial dysregulation may promote vasoconstriction, smooth muscle cell proliferation and vascular stiffness and further promote vascular inflammation. This acute-reactant protein may thus be not merely a marker of inflammation but also have modulatory functions that may contribute to the progression of arterial stiffness. Finally, an alternative explanation for our findings could be that increased hs-CRP levels are a consequence of the arterial stiffening. 21 Higher levels of arterial stiffness are associated with larger flow reversals during diastole, and reversed flow can increase the expression of adhesion molecules, which would tend to promote the inflammatory process.
In summary, the association that we observed between CRP and measures of arterial stiffness adds to the evidence that links chronic low-grade inflammation to functional alterations of large arteries.
